Biochemical parameters in neuroblastoma

Indian Journal of Clinical Biochemistry

Volumn 23, Issue 3, 2008, Pages 293-295

  Bolkar, S T ^a   Ghadge, M S ^a   Raste, A S ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

Biochemical parameters; Neuroblastoma; Neuron specific enolase; Vanillyl mandellic acid

Indexed keywords

ENOLASE; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; VANILMANDELIC ACID;

ARTICLE; BLOOD LEVEL; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; MOBILIZATION; NEUROBLASTOMA; PATIENT REFERRAL; URINALYSIS;

EID: 56849086836     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12291-008-0066-7     Document Type: Article

References (12)

1. Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, et al. Screening for neuroblastoma in France: Methodological aspects and preliminary observations. Med Paed Oncol 1997; 28: 81-91.
2. Berthold F, Harms D, Lampert F, Niethammer D, Zieschang J. Risk factors in neuroblastoma in infants. Contrib Oncol 1990; 41: 101-17.
3. Carlsen NLT. Prognostic factors in neuroblastoma of childhood. Current problems. Paediatr Rev Commun 1991; 6 : 63-77.
4. Berthold F, Trechow R,Utsch S, Zieschang J. Prognostic factors in metastatic neuroblastomas. A multivariate analysis of 182 cases. Am J Pediatr Hematol Oncol 1992; 14: 207-15.
5. LaBrosse EH, Com-Nougue C, Zucker JM, Comoy E, Bohuon C, Lemerie J, etal. Urinary excretion of 3-methoxy-4- hydroxyl phenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors. Cancer Res 1980; 40: 1995-2001.
6. Anon : Z Klin Chem Biochem (Quoted from the application notes of Boehringer Mannheim for Hitachi 705) 1970; 8: 658.
7. Szasz G. A Kinetic photometric method for serum gamma glutamyl transpeptidase. Clin Chem 1976; 15:124-36.
8. Schleiermacher GH, Rubie H, Hartman O, Bergeron C, Chastagner P, Mechinaud F, et al. Treatment of stage 4s neuroblastoma - report of 10 years experience of the French Society of Paediatric Oncology 2003; 89 : 470-76.
9. Tapia FJ, Polak JM, Barbosa AJA, Bloom SR, Marangos PJ, Dermody C, et al. Neuron-specific enolase is produced by neuroendocrine tumors. Lancet 1981; i: 808-11.
10. Carney DN, Marangos PJ, Ihde DC, Bunn PA Jr, Cohen MH, Minna JD, et al. Serum neuron-specific enolase a marker for disease extent and response to therapy of small cell lung cancer. Lancet 1982; i: 583-86.
11. Ishiguro Y, Katu K, Shinmizu A, Ita T, Nagaya M. High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma. Clin Chim Acta 1982; 121:173-80.
12. Bertani - Dziedzic L, Dziedzic SW, Gitlow SE. Catecholamine metabolism in neuroblastoma in Pochedly C (ed): Neuroblastoma: Tumor Biology and Therapy Boca Raton Fl. CRC, 1990; 69-91.